Histone lysine lactylation (Kla), an epigenetic modification once overlooked, has emerged as a critical regulator in the complex orchestration of cancer progression, exerting its influence over tumor metabolism, immunity, and additional biological mechanisms (27). The gene discussed is KL; the disease is neoplasm.